{"result": "(\"entity\"<|>RPMI<|>ORGANIZATION<|>RPMI is a complete medium used for culturing T cells, containing various supplements such as fetalcalf serum, hepes, sodium pyruvate, nonessential amino acids, penicillin-streptomycin, and L-glutamine)\n##\n(\"entity\"<|>ANTI-CD3 MAB<|>ORGANIZATION<|>Anti-CD3 mAb, clone TR66, is a monoclonal antibody produced in-house used for T cell activation)\n##\n(\"entity\"<|>ANTI-CD28 MAB<|>ORGANIZATION<|>Soluble anti-CD28 mAb, clone CD28.2 from BD, is used alongside anti-CD3 mAb for T cell activation)\n##\n(\"entity\"<|>IL-12<|>ORGANIZATION<|>IL-12 from Prepotech is used in T cell culture to influence cell activation and cytokine secretion)\n##\n(\"entity\"<|>LEGENDPLEX IMMUNOASSAY<|>ORGANIZATION<|>LEGENDplex Immunoassay by Biolegend is used for assessing cytokine secretion in cell culture supernatants)\n##\n(\"entity\"<|>BD BIOSCIENCES<|>ORGANIZATION<|>BD Biosciences provides various products for cell culture and flow cytometry, including Fix/Perm kit and GolgiPlug monensin)\n##\n(\"entity\"<|>THERMOFISHER SCIENTIFIC<|>ORGANIZATION<|>ThermoFisher Scientific supplies the live/dead marker for viability assessment in cell staining)\n##\n(\"entity\"<|>FLOWJO<|>ORGANIZATION<|>FlowJo, LLC, USA, provides software for analyzing flow cytometry data)\n##\n(\"entity\"<|>GET-SANTÉ<|>ORGANIZATION<|>GeT-Santé (I2MC, Toulouse, France) is a core facility for library quantification in RNA sequencing)\n##\n(\"entity\"<|>GET-PLAGE<|>ORGANIZATION<|>GeT-PlaGe (INRAE, Toulouse, France) is a core facility for sequencing in RNA sequencing projects)\n##\n(\"entity\"<|>ILLUMINA<|>ORGANIZATION<|>Illumina, based in San Diego, USA, manufactures the NovaSeq 6000 instrument used for RNA sequencing)\n##\n(\"entity\"<|>ROCHE<|>ORGANIZATION<|>Roche, based in Basel, Switzerland, provides the KAPA Library Quantification Kit for accurate library quantification in RNA sequencing)\n##\n(\"entity\"<|>PREPOTECH<|>ORGANIZATION<|>Prepotech supplies IL-2 used in the expansion of primary isolated CD8 cells)\n##\n(\"relationship\"<|>ANTI-CD3 MAB<|>RPMI<|>Anti-CD3 mAb is used in RPMI medium for T cell activation<|>5)\n##\n(\"relationship\"<|>ANTI-CD28 MAB<|>RPMI<|>Soluble anti-CD28 mAb is used in RPMI medium alongside anti-CD3 mAb for T cell activation<|>5)\n##\n(\"relationship\"<|>IL-12<|>RPMI<|>IL-12 is used in RPMI medium for influencing T cell activation and cytokine secretion<|>5)\n##\n(\"relationship\"<|>LEGENDPLEX IMMUNOASSAY<|>BD BIOSCIENCES<|>LEGENDplex Immunoassay, used for cytokine assessment, is a product that complements BD Biosciences' cell culture and flow cytometry products<|>4)\n##\n(\"relationship\"<|>FLOWJO<|>BD BIOSCIENCES<|>FlowJo software is used for analyzing data from flow cytometry, a technique supported by BD Biosciences products<|>4)\n##\n(\"relationship\"<|>GET-SANTÉ<|>ILLUMINA<|>GeT-Santé performs library quantification for RNA sequencing, which is conducted on Illumina's NovaSeq 6000 instrument<|>5)\n##\n(\"relationship\"<|>GET-PLAGE<|>ILLUMINA<|>GeT-PlaGe performs sequencing for RNA sequencing projects on Illumina's NovaSeq 6000 instrument<|>5)\n##\n(\"relationship\"<|>PREPOTECH<|>RPMI<|>Prepotech's IL-2 is used in RPMI medium for the expansion of primary isolated CD8 cells<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: T cells were cultured in complete medium RPMI (10% fetalcalf serum, 1% hepes, 1% sodium pyruvate, 1% nonessential\namino acids, 1% penicillin-streptomycin, 1%\nL-glutamine) for\n3 days in the presence of 1 μg/mL coated anti-CD3 mAb\n(clone TR66, produced in house) with or without 1 μg/mL\nsoluble anti-CD28 mAb (clone CD28.2, BD) or IL-12 (Pre-\npotech). After 3 days of activation, cell culture supernatantsGlossary\nAKT = serine/threonine protein kinase; CM= central memory; EM=eﬀector memory; ERK = extracellular signal-regulated\nkinase; FLT1 = Fms-related receptor tyrosine kinase 1; MAPK = mitogen-activated protein kinase; MFI = mean ﬂuorescent\nintensity; MS= multiple sclerosis; OSM = oncostatin M; PBMC = peripheral blood mononuclear cells; SNP = single-nucleotide\npolymorphism; SPHK1 = sphingosine kinase 1; TCR = T-cell receptor.\nNeurology: Neuroimmunology & Neuroinflammation | Volume 11, Number 6 | November 2024 Neurology.org/NN\ne200306(2)\nwere frozen at −20°C. Cytokine secretion was assessed using\nthe CD8/NK panel LEGENDplex Immunoassay (Biolegend)\nfollowing the manufacturer ’s instructions.\nFlow Cytometry\nSurface staining was performed for 30 minutes at 4°C in the dark.\nCells were then ﬁxed and permeabilized using the Fix/Perm kit\n(BD) for 30 minutes at RT and were stained for intracellularmarkers for 30 minutes at RT. For cytokine production, the cells\nwere stimulated for 4 hours with 100 ng/mL of PMA, 1 μg/mL\nof ionomycin, and 1 μg/mL of the GolgiPlug monensin (BD\nBiosciences). Between each step, cells were washed twice with\nﬂuorescence-activated cell sorting bu ﬀer containing 2% FCS.\nThe live/dead marker (ThermoFisher Scienti ﬁc) was included\nin the staining to assess the viability. Proliferation was measured\nusing the Cell Trace Violet kit (ThermoFisher) following themanufacturer ’s instructions. Isotype controls and ﬂuorescence\nm i n u so n es a m p l e sw e r eu s e da sc o n t r o la n dt os e tt h eg a t i n g .\nCells were analyzed by ﬂow cytometry using the Fortessa and\nLSRII ﬂow cytometers (BD Biosciences, USA) and FlowJo\nsoftware (version V10, FlowJo, LLC, USA).\nRNA Sequencing\nFluorescence-activated cell-sorted CD3\n+CD8+cells were cul-\ntured in complete medium RPMI for 0, 4, and 24 hours in the\npresence of 1 μg/mL coated anti-CD3 mAb (clone TR66,\nproduced in-house) and 1 μg/mL soluble anti-CD28 mAb\n(clone CD28.2, BD). RNA was extracted using the RNeasy\nMicro Kit (Qiagen) following the manufacturer ’si n s t r u c t i o n s .\nLibraries were prepared using the Illumina Stranded Total RNA\nPrep kit starting from 7.5 ng of total RNA and using 14 PCR\ncycles for library ampli ﬁcation. The kit for the index sequences\nused was IDT Illumina RNA UDI A Lig 96 Indexes 96 Spl.\nLibrary pool quanti ﬁcation and sequencin g were performed at\nthe GeT-Sant´ e (I2MC, Toulouse, France) and GeT-PlaGe\n(INRAE, Toulouse, France) core facilities, respectively. The\npool was quanti ﬁed by qPCR using the KAPA Library Quanti-\nﬁcation Kit (Roche, Basel, Switzerland) to obtain an accurate\nquanti ﬁcation. Subsequently, sequencing was conducted on a\nsingle S4 lane of the Illumina NovaSeq 6000 instrument (Illu-\nmina, San Diego, USA), using the NovaSeq 6000 S4 v1.5 Re-agent Kit (300 cycles) and a paired-end 2 × 150 pb strategy. Each\nlibrary yielded between 20 and 44 million paired-end raw reads.\nSimple Western\nPrimary isolated CD8 cells were expanded on activation withphytohemagglutinin (PHA) in complete medium RPMI for 10\ndays in the presence of 100U/mL I L-2 (Prepotech). Expanded\nCD8 T cells were then stimulated with either 0.5 μg/mL anti-\nC D 3( U C H T - 1 ,B D )a n d1 μg/mL anti-CD28 (clone CD28.2,\nBD) monoclonal antibodies or LEAF-puri ﬁed mouse IgG1 iso-\ntype control. Cells were incubated with the speci ﬁed antibodies for\n30 minutes on ice, followed by washing with an ice-cold medium\nand suspension in a warm medium for 5 minutes at 37°C. Anti-\nbodies were cross-linked using the\n######################\nOutput:", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}